Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-κB activation and endothelial cell survival

Oncogene

Volumn 26, Issue 39, 2007, Pages 5722-5732

  Bieler, G ^a,b,e   Hasmim, M ^a,e   Monnier, Y ^a,b,e   Imaizumi, N ^a,b,e   Ameyar, M ^a,c,e   Bamat, J ^b   Ponsonnet, L ^a,e   Chouaib, S ^c   Grell, M ^d   Goodman, S L ^d   Lejeune, F ^a,e   Ruegg C ^a,b,e  

^a Centre du cancer de Lausanne   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d MERCK KGAA   (Germany)

^e CNRS   (France)

Author keywords

Angiogenesis; Cancer; Cell death; Endothelium; Signaling

Indexed keywords

ACTIN; ALPHAVBETA5 INTEGRIN; ANTINEOPLASTIC AGENT; CILENGITIDE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; VITRONECTIN RECEPTOR;

ACTIN FILAMENT; ADHESION; ARTICLE; CELL ADHESION; CELL DEATH; CELL DISRUPTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIGATION; PRIORITY JOURNAL; STRESS FIBER;

ACTINS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; CYTOSKELETON; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; INTEGRIN ALPHAVBETA3; INTEGRINS; MAP KINASE KINASE 4; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548187466     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210354     Document Type: Article

References (40)

1. Agrawal S, Agarwal ML, Chatterjee-Kishore M, Stark GR, Chisolm GM. (2002). Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Mol Cell Biol 22: 1981-1992.
2. Alghisi GC, Ruegg C. (2006). Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 13: 113-135.
3. Baker SJ, Reddy EP. (1998). Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261-3270.
4. Balkwill FR, Ward BG, Moodie E, Fiers W. (1987). Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer. Cancer Res 47: 4755-4758.
5. Battle TE, Frank DA. (2002). The role of STATs in apoptosis. Curr Mol Med 2: 381-392.
6. Beg AA, Baltimore D. (1996). An essential role for NF-kappa-B in preventing TNF-alpha-induced cell death. Science 274: 782-784.
7. Beyaert R, Van Loo G, Heyninck K, Vandenabeele P. (2002). Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int Rev Cytol 214: 225-272.
8. Bezzi M, Hasmim M, Bieler G, Dormond O, Ruegg C. (2003). Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. J Biol Chem 278: 43603-43614.
9. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. (1995). Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
10. Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS et al. (2000). PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun 271: 342-345.
11. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ et al. (2000). A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 6: 851-860.
12. Cai Z, Korner M, Tarantino N, Chouaib S. (1997). IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 272: 96-101.
13. Chen JX, Chen Y, DeBusk L, Lin W, Lin PC. (2004). Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis. Am J Physiol Heart Circ Physiol 287: H187-H195.
14. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9: 899-909.
15. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M et al. (1999). Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 96: 9815-9820.
16. Dechantsreiter MA, Planker E, Matha B, Lohof E, Holzemann G, Jonczyk A et al. (1999). N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem 42: 3033-3040.
17. Fornaro M, Plescia J, Chheang S, Tallini G, Zhu YM, King M et al. (2003). Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem 278: 50402-50411.
18. Gooch JL, Herrera RE, Yee D. (2000). The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ 11: 335-342.
19. Gourlay CW, Ayscough KR. (2005). The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 6: 583-589.
20. Hermann C, Assmus B, Urbich C, Zeiher AM, Dimmeler S. (2000). Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20: 402-409.
21. Imose M, Nagaki M, Naiki T, Osawa Y, Brenner DA, Asano T et al. (2003). Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice. Liver Int 23: 386-396.
22. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793.
23. Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B et al. (2002). Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35: 697-709.
24. Korff T, Augustin HG. (1998). Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143: 1341-1352.
25. Laird SM, Graham A, Paul A, Gould GW, Kennedy C, Plevin R. (1998). Tumour necrosis factor stimulates stress-activated protein kinases and the inhibition of DNA synthesis in cultures of bovine aortic endothelial cells. Cell Signal 10: 473-480.
26. Lejeune FJ, Lienard D, Matter M, Ruegg C. (2006). Efficiency of recombinant human TNF in human cancer therapy. Cancer Immun 6: 6.
27. Mareel M, Dragonetti C, Tavernier J, Fiers W. (1988). Tumor-selective cytotoxic effects of murine tumor necrosis factor (TNF) and interferon-gamma (IFN-gamma) in organ culture of B16 melanoma cells and heart tissue. Int J Cancer 42: 470-473.
28. Meredith Jr J, Fazeli B, Schwartz MA. (1993). The extracellular matrix as a cell survival factor. Mol Biol Cell 4: 953-961.
29. Nolop KB, Ryan US. (1990). Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide. Am J Physiol 259: L123-9.
30. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F et al. (2000). Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275: 9102-9105.
31. Pober JS. (1998). Activation and injury of endothelial cells by cytokines. Pathol Biol (Paris) 46: 159-163.
32. Rüegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ. (1998). Evidence for the involvement of endothelial cell integrin alpha-v-beta-3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 4: 408-414.
33. Scanlon M, Laster SM, Wood JG, Gooding LR. (1989). Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments. Proc Natl Acad Sci USA 86: 182-186.
34. Shyy JY, Chien S. (2002). Role of integrins in endothelial mechanosensing of shear stress. Circ Res 91: 769-775.
35. Spagnuolo R, Corada M, Orsenigo F, Zanetta L, Deuschle U, Sandy P et al. (2004). Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood 103: 3005-3012.
36. Suk K, Kim S, Kim YH, Kim KA, Chang I, Yagita H et al. (2001). IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 166: 4481-4489.
37. Surapisitchat J, Hoefen RJ, Pi X, Yoshizumi M, Yan C, Berk BC. (2001). Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc Natl Acad Sci USA 98: 6476-6481.
38. Thorburn A. (2004). Death receptor-induced cell killing. Cell Signal 16: 139-144.
39. Yilmaz A, Bieler G, Spertini O, Lejeune FJ, Ruegg C. (1998). Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon-gamma results in simultaneous synergistic and reversible effects on proliferation and morphology. Int J Cancer 77: 592-599.
40. Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC et al. (2005). Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 24: 3954-3963.